New Delhi, May 28: An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more effectively, according to preliminary results of a clinical trial. The drug, lamivudine, could represent an important new option for millions of patients with diabetic macular edema (DME) — a condition affecting about one in.
